Amedeo Smart

Free Medical Literature Service

 

Amedeo

Asthma
  Free Subscription

Articles published in
Int Arch Allergy Immunol
    April 2024
  1. LIU YL, Zhang Y
    Prediction of Clinical Response to Dupilumab in Patients with Severe Asthma Using Fractional Exhaled Nitric Oxide Combined with Pulmonary Function Testing.
    Int Arch Allergy Immunol. 2024 Apr 30:1-9. doi: 10.1159/000538542.
    >> Share

  2. MAO Z, Ding Z, Liu Z, Shi Y, et al
    miR-21-5p Modulates Airway Inflammation and Epithelial-Mesenchymal Transition Processes in a Mouse Model of Combined Allergic Rhinitis and Asthma Syndrome.
    Int Arch Allergy Immunol. 2024 Apr 8:1-11. doi: 10.1159/000538252.
    >> Share

    March 2024
  3. HUANG J, Cai H, Ye X, Zhang G, et al
    Demethylzeylasteral (T-96) Alleviates Allergic Asthma via Inhibiting MAPK/ERK and NF-kappaB Pathway.
    Int Arch Allergy Immunol. 2024 Mar 25:1-10. doi: 10.1159/000537837.
    >> Share

  4. POTACZEK DP, Bazan-Socha S, Wypasek E, Wygrecka M, et al
    Recent Developments in the Role of Histone Acetylation in Asthma.
    Int Arch Allergy Immunol. 2024 Mar 22:1-11. doi: 10.1159/000536460.
    >> Share

  5. GUO X, Sun W, Zhang B
    Monotropein Alleviates Ovalbumin-Induced Asthma in Mouse Model by Inhibiting AKT/NF-kappaB Pathway.
    Int Arch Allergy Immunol. 2024 Mar 1:1-11. doi: 10.1159/000535450.
    >> Share

  6. YU R, Wang X, Wang H, Lu X, et al
    Associations between Proton-Pump Inhibitor Usage, Allergy, and Asthma: An Analysis of NHANES 2005-2006.
    Int Arch Allergy Immunol. 2024 Mar 1:1-8. doi: 10.1159/000535156.
    >> Share

    January 2024
  7. SHU M, Xu H, Liang Y, Shi M, et al
    Long Non-Coding RNA BCYRN1 Drives Cellular Processes to Promote Asthma Development.
    Int Arch Allergy Immunol. 2024 Jan 15:1-12. doi: 10.1159/000535868.
    >> Share

  8. LIN L, Dai F, Wei J, Chen Z, et al
    Biological Roles of 5-Oxo-6,8,11,14-Eicosatetraenoic Acid and the OXE Receptor in Allergic Diseases: Collegium Internationale Allergologicum Update 2024.
    Int Arch Allergy Immunol. 2024 Jan 4:1-10. doi: 10.1159/000535560.
    >> Share

  9. MATSUNO O
    Factors Affecting the Ability to Discontinue Oral Corticosteroid Use in Patients with EGPA Treated with Anti-Interleukin-5 Therapy.
    Int Arch Allergy Immunol. 2024;185:116-123.
    >> Share

  10. CAKMAK ME, Yegit OO, Oztop N
    A Case-Control Study Comparing the General Characteristics of Patients with Symptomatic Dermographism and Chronic Spontaneous Urticaria: Is Atopy a Risk Factor for Symptomatic Dermographism?
    Int Arch Allergy Immunol. 2024;185:247-252.
    >> Share

    December 2023
  11. LIU L, Tian F, Sun Y, Li G, et al
    Exploring the Autoimmune Pathogenesis in Severe Asthma.
    Int Arch Allergy Immunol. 2023 Dec 7:1-7. doi: 10.1159/000535310.
    >> Share

    November 2023
  12. BRAVO-GUTIERREZ FJ, Miralles-Lopez JC, Valverde-Molina J, Alemany Frances ML, et al
    Effectiveness of Mepolizumab in Patients with Severe Eosinophilic Asthma with/without Nasal Polyposis: A Real-Life Study.
    Int Arch Allergy Immunol. 2023 Nov 30:1-7. doi: 10.1159/000534902.
    >> Share

  13. CAKMAK ME, Oztop N, Yegit OO
    Comparison of the General Characteristics of Patients with Severe Asthma Who Switched from Omalizumab to Mepolizumab versus Patients Who Responded to Omalizumab Treatment: A Real-Life Study.
    Int Arch Allergy Immunol. 2023 Nov 22:1-9. doi: 10.1159/000534907.
    >> Share

  14. LIU HM, Rayner A, Mendelsohn AR, Shneyderman A, et al
    Applying Artificial Intelligence to Identify Common Targets for Treatment of Asthma, Eczema, and Food Allergy.
    Int Arch Allergy Immunol. 2023 Nov 21:1-12. doi: 10.1159/000534827.
    >> Share

    October 2023
  15. OGUZULGEN K, Ozturk AB, Bacceoglu A, Aydin O, et al
    Inhaler Steroid Use Changes Oral and Airway Bacterial and Fungal Microbiome Profile in Asthma Patients.
    Int Arch Allergy Immunol. 2023 Oct 16:1-10. doi: 10.1159/000531866.
    >> Share

    September 2023
  16. CHIANG TY, Lee HY, Chien WC, Su HC, et al
    The Relationship between Allergic Disease and Sexual Dysfunction: A Scoping Review.
    Int Arch Allergy Immunol. 2023 Sep 20:1-13. doi: 10.1159/000533403.
    >> Share

  17. TONG N, Liu D, Lu L, Lin R, et al
    miR-410 Regulates Helper T Cell Differentiation in Ovalbumin-Induced Asthma through the PI3K-AKT-VEGF Signaling Pathway.
    Int Arch Allergy Immunol. 2023 Sep 19:1-9. doi: 10.1159/000531493.
    >> Share

  18. LI Y, Zou C, Li J, Wang W, et al
    Airway Microbiome Composition and Co-Occurrence Network Are Associated with Inflammatory Phenotypes of Asthma.
    Int Arch Allergy Immunol. 2023 Sep 8:1-10. doi: 10.1159/000533315.
    >> Share

  19. WANG H, Wang J, Song Z, Guo J, et al
    Risk Factors for Acute Rhinosinusitis in Childhood Asthma.
    Int Arch Allergy Immunol. 2023 Sep 5:1-5. doi: 10.1159/000533329.
    >> Share

    August 2023
  20. SATO E, Seo Y, Tagaya E, Yagi O, et al
    Higher Prevalence and Severity of Eosinophilic Otitis Media in Patients with Asthma-COPD Overlap Compared with Asthma Alone.
    Int Arch Allergy Immunol. 2023 Aug 24:1-10. doi: 10.1159/000531980.
    >> Share

  21. SHIMIZU M, Kato T, Adachi Y, Wada T, et al
    Maternal Dietary Vitamin D Intake during Pregnancy Is Associated with Allergic Disease Symptoms in Children at 3 Years Old: The Japan Environment and Children's Study.
    Int Arch Allergy Immunol. 2023 Aug 22:1-10. doi: 10.1159/000531970.
    >> Share

  22. GUO J, Wang J, Xu X, Yang Y, et al
    Risk Factors for Abnormal Small Airway Function Indicators in Nasal Polyp Patients with and without Asthma.
    Int Arch Allergy Immunol. 2023 Aug 18:1-7. doi: 10.1159/000532068.
    >> Share

  23. CAO J, Liu M, Wang Z, Huang Y, et al
    Interaction between Serum Cotinine and Magnesium Intake with Childhood Asthma: A Cross-Sectional Study.
    Int Arch Allergy Immunol. 2023 Aug 18:1-9. doi: 10.1159/000531730.
    >> Share

  24. XU C, Du L, Guo Y, Liang Y, et al
    TCN1 Expression Is Increased in Asthma.
    Int Arch Allergy Immunol. 2023 Aug 16:1-8. doi: 10.1159/000531073.
    >> Share

  25. STRUSS N, Dieter S, Schwarz K, Badorrek P, et al
    Sodium Chloride versus Lactose as a Carrier for House Dust Mite Allergen in Allergen Chamber Studies: A Clinical Study to Assess Noninferiority.
    Int Arch Allergy Immunol. 2023 Aug 16:1-10. doi: 10.1159/000531878.
    >> Share

    July 2023
  26. YILDIZ E, Colkesen F, Arslan S, Evcen R, et al
    Allergic Diseases as a Clinical Phenotype Marker in Patients with Common Variable Immunodeficiency.
    Int Arch Allergy Immunol. 2023 Jul 20:1-9. doi: 10.1159/000530901.
    >> Share

  27. GAO Y, Li J, Xu X, Wang C, et al
    Sensitisation to House Dust Mite Component Der p 23 Is Associated with Severe Symptoms and Asthma in Allergic Rhinitis Patients.
    Int Arch Allergy Immunol. 2023 Jul 12:1-8. doi: 10.1159/000531244.
    >> Share

    June 2023
  28. SIO YY, Gan WL, Ng WS, Matta SA, et al
    The ERBB2 Exonic Variant Pro1170Ala Modulates Mitogen-Activated Protein Kinase Signaling Cascades and Associates with Allergic Asthma.
    Int Arch Allergy Immunol. 2023 Jun 19:1-12. doi: 10.1159/000530960.
    >> Share

  29. GU Z, Wei P, Kou W, Tang XY, et al
    Analysis of Multimorbidity of Moderate to Severe Allergic Rhinitis in Children: A Real-World Study.
    Int Arch Allergy Immunol. 2023 Jun 8:1-11. doi: 10.1159/000530842.
    >> Share

    May 2023
  30. SAKAI N, Koya T, Murai Y, Tsubokawa F, et al
    Effect of Benralizumab on Mucus Plugs in Severe Eosinophilic Asthma.
    Int Arch Allergy Immunol. 2023 May 16:1-9. doi: 10.1159/000530392.
    >> Share

  31. SIO YY, Shi P, Matta SA, Fok YTR, et al
    Functional Polymorphisms of the Arachidonic Acid Pathway Associate with Risks and Clinical Outcomes of Allergic Diseases.
    Int Arch Allergy Immunol. 2023;184:609-623.
    >> Share

    March 2023
  32. OHBAYASHI H, Hozawa S, Bertran A, Yoshisue H, et al
    Prevalence of Uncontrolled Asthma despite Treatment with Medium- or High-Dose ICS/LABA Using Patient-Reported Outcomes in Japan: The KOCU (KnOwing the Controlled statUs of Asthma in Japan) Study.
    Int Arch Allergy Immunol. 2023 Mar 30:1-12. doi: 10.1159/000529251.
    >> Share

  33. CAKMAK ME, Oztop N, Yegit OO, Ozdedeoglu O, et al
    Evaluation of the Clinical Features and Laboratory Data of Patients with Severe Eosinophilic Asthma Classified as Super-Responders, Partial Responders, or Nonresponders to Mepolizumab Treatment: A Real-Life Study.
    Int Arch Allergy Immunol. 2023 Mar 30:1-8. doi: 10.1159/000529760.
    >> Share

  34. YUKSEL ASLIER NG, Saatci O, Aslier M
    Disease and Quality of Life Aspects of Cat Allergy in Non-Pet Owners with Allergic Rhinitis.
    Int Arch Allergy Immunol. 2023 Mar 29:1-9. doi: 10.1159/000529275.
    >> Share

    February 2023
  35. WANG D, Ito C, Homma Y, Arimitsu M, et al
    Prevalence and Clinical Characteristics of Patients with Moderate-to-Severe Asthma in Japan Using a JMDC Claims Database.
    Int Arch Allergy Immunol. 2023 Feb 16:1-9. doi: 10.1159/000528987.
    >> Share

    January 2023
  36. XU C, Du L, Guo Y, Liang Y, et al
    Differential Circular RNA Expression Profiles in Induced Sputum of Patients with Asthma.
    Int Arch Allergy Immunol. 2023 Jan 23:1-11. doi: 10.1159/000528129.
    >> Share

  37. ROGER A, Lazo C, Arias N, Quirant B, et al
    Using Component-Resolved Diagnosis to Characterize the Sensitization to Specific Cat and Dog Allergens in Patients with Allergic Respiratory Diseases in Catalonia, Spain.
    Int Arch Allergy Immunol. 2023 Jan 19:1-7. doi: 10.1159/000528643.
    >> Share

  38. FENG H, Xiong X, Chen Z, Xu Q, et al
    Prevalence and Influencing Factors of Food Allergy in Global Context: A Meta-Analysis.
    Int Arch Allergy Immunol. 2023 Jan 12:1-33. doi: 10.1159/000527870.
    >> Share

  39. ZHANG Z, Li G, Yu L, Jiang J, et al
    Using a Two-Sample Mendelian Randomization Study Based on Genome-Wide Association Studies to Assess and Demonstrate the Causal Effects of Allergic Rhinitis on Chronic Lower Respiratory Diseases and Lung Function.
    Int Arch Allergy Immunol. 2023 Jan 11:1-9. doi: 10.1159/000528350.
    >> Share

  40. BU ML, Li MH, Feng M, Wang JR, et al
    Poly(I:C) Exacerbates Airway Goblet Cell Hyperplasia and Lung Inflammation in HDM-Exposed Balb/C Mice by YAP/FOXM1 Pathway.
    Int Arch Allergy Immunol. 2023;184:707-719.
    >> Share

  41. SATO S, Kawano T, Ike E, Takahashi K, et al
    IL-1beta Derived Th17 Immune Responses Are a Critical Factor for Neutrophilic-Eosinophilic Airway Inflammation on Psychological Stress-Induced Immune Tolerance Breakdown in Mice.
    Int Arch Allergy Immunol. 2023;184:797-807.
    >> Share

    December 2022
  42. PATCHETT BJ, Nriagu BN, Mavraj G, Patel RR, et al
    Allergic Polysensitization Clusters: Newly Recognized Severity Marker in Urban Asthmatic Adults.
    Int Arch Allergy Immunol. 2022 Dec 21:1-12. doi: 10.1159/000526706.
    >> Share

  43. ABBASI-DOKHT T, Sadrifar S, Forouzandeh S, Malek F, et al
    Multistrain Probiotics Supplement Alleviates Asthma Symptoms via Increasing Treg Cells Population: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Int Arch Allergy Immunol. 2022 Dec 9:1-11. doi: 10.1159/000526739.
    >> Share

  44. TSUBOKAWA F, Koya T, Murai Y, Tanaka K, et al
    Effects of Benralizumab on Three-Dimensional Computed Tomography Analysis in Severe Eosinophilic Asthma.
    Int Arch Allergy Immunol. 2022 Dec 5:1-9. doi: 10.1159/000525846.
    >> Share

  45. AKARSU A, Oksel Karakus C, Ocak M, Oral N, et al
    Exploring the Heterogeneity of IgE-Mediated Food Allergy through Latent Class Analysis.
    Int Arch Allergy Immunol. 2022 Dec 5:1-8. doi: 10.1159/000527534.
    >> Share

  46. HOTTA M, Ueda K, Ikehara S, Tanigawa K, et al
    The Duration of Neonatal Phototherapy and Allergic Disorders: The Japan Environment and Children's Study.
    Int Arch Allergy Immunol. 2022 Dec 5:1-9. doi: 10.1159/000527381.
    >> Share

    November 2022
  47. LYLY A, Genberg E, Kauppi P, Virkkula P, et al
    Real-Life Experience of Biologic Treatment for Asthma on Chronic Rhinosinusitis: A Finnish Cohort.
    Int Arch Allergy Immunol. 2022 Nov 7:1-12. doi: 10.1159/000526365.
    >> Share

  48. YAVUZ ST, Koc O, Kaya G, Gulec M, et al
    Risk Factors for Exacerbations in School-Age Children with Asthma.
    Int Arch Allergy Immunol. 2022 Nov 3:1-7. doi: 10.1159/000527220.
    >> Share

    October 2022
  49. SUN Y, Xia T, Ma J, Sun Y, et al
    IL-12 Contributes to the Development of Asthma by Targeting HIF-1alpha/NLRP3 Pathway through Runx3.
    Int Arch Allergy Immunol. 2022 Oct 12:1-10. doi: 10.1159/000526803.
    >> Share

  50. KIM MH, Sohn KH, Park HJ, Nam YH, et al
    Multicenter Prospective Observational Study to Evaluate the Therapeutic Effect and Safety of a Combination of Montelukast and Levocetirizine for Allergic Rhinitis when Administered to Patients with Allergic Rhinitis and Asthma.
    Int Arch Allergy Immunol. 2022 Oct 7:1-8. doi: 10.1159/000526094.
    >> Share

  51. KAMA Y, Yamada Y, Koike T, Enseki M, et al
    Allergic Sensitization Is Crucial for the Suppressive Role of Streptococcus pneumoniae in the Acute Exacerbation of Asthma.
    Int Arch Allergy Immunol. 2022 Oct 6:1-11. doi: 10.1159/000526408.
    >> Share

    September 2022
  52. GIULIANO AFM, Buquicchio R, Patella V, Bedbrook A, et al
    Rediscovering Allergic Rhinitis: The Use of a Novel mHealth Solution to Describe and Monitor Health-Related Quality of Life in Elderly Patients.
    Int Arch Allergy Immunol. 2022 Sep 6:1-11. doi: 10.1159/000525595.
    >> Share

  53. DU L, Xu C, Shi J, Tang L, et al
    Elevated CXCL14 in Induced Sputum Was Associated with Eosinophilic Inflammation and Airway Obstruction in Patients with Asthma.
    Int Arch Allergy Immunol. 2022 Sep 5:1-10. doi: 10.1159/000526367.
    >> Share

    August 2022
  54. ARSLAN B, Pacaci Cetin G, Turk M, Gulmez I, et al
    Discontinuing Omalizumab Treatment in Super-Responder Patients with Allergic Severe Asthma: Can the Baseline Total IgE Level Be Used as a Biological Marker to Decide Discontinuing Omalizumab Treatment?
    Int Arch Allergy Immunol. 2022 Aug 2:1-7. doi: 10.1159/000525723.
    >> Share

    June 2022
  55. YANG Y, Huang G, Xu Q, Zhao G, et al
    miR-146a-5p Attenuates Allergic Airway Inflammation by Inhibiting the NLRP3 Inflammasome Activation in Macrophages.
    Int Arch Allergy Immunol. 2022 Jun 3:1-12. doi: 10.1159/000524718.
    >> Share

    May 2022
  56. KOJIMA R, Shinohara R, Kushima M, Horiuchi S, et al
    Prenatal Negative Life Events and Childhood Allergies: The Japan Environment and Children's Study (JECS).
    Int Arch Allergy Immunol. 2022 May 19:1-9. doi: 10.1159/000524854.
    >> Share

  57. ZONG W, Liang Y, Mo Y
    Increased SERPINB10 Expression in Induced Sputum Was Associated with Airway Type 2 Inflammation in Asthma.
    Int Arch Allergy Immunol. 2022 May 6:1-7. doi: 10.1159/000524613.
    >> Share

    April 2022
  58. CHEN L, Wang W, Leng Q, Cong L, et al
    Associations of the Methylation Levels of NFAT5, PVT1, RPS6KA1, and MIB1 with Steroid-Resistant Asthma.
    Int Arch Allergy Immunol. 2022 Apr 13:1-12. doi: 10.1159/000524080.
    >> Share

    March 2022
  59. HUANG QP, Xie ZF, Huang J
    Assessment of the Association between Genetic Polymorphisms in the CHI3L1 Gene and Asthma Risk.
    Int Arch Allergy Immunol. 2022 Mar 25:1-12. doi: 10.1159/000522393.
    >> Share

    February 2022
  60. ZONG W, Mo Y, Liang Y
    Correlation between Increased Monocyte Chemotactic Protein 1 Level and Lung Function in Patients with Asthma.
    Int Arch Allergy Immunol. 2022 Feb 23:1-9. doi: 10.1159/000521946.
    >> Share

  61. SCHIFFER M, Peters K, Peters M
    Comparison of Airway Remodeling in Two Different Endotypes of Allergic Asthma.
    Int Arch Allergy Immunol. 2022 Feb 22:1-12. doi: 10.1159/000522189.
    >> Share

  62. XU C, Du L, Zeng Z, Chen F, et al
    Elevated CEACAM5 Levels in Patients with Asthma.
    Int Arch Allergy Immunol. 2022 Feb 16:1-9. doi: 10.1159/000521754.
    >> Share

  63. FENG Y, Zhang S, Shang Y, Chen N, et al
    The Use of Exercise Challenge Testing and Fractional Exhaled Nitric Oxide in Diagnosis of Chest Tightness Variant Asthma in Children.
    Int Arch Allergy Immunol. 2022 Feb 14:1-8. doi: 10.1159/000522062.
    >> Share

  64. RYDELL N, Nagao M, Moverare R, Ekoff H, et al
    Serum Eosinophilic Cationic Protein Is a Reliable Biomarker for Childhood Asthma.
    Int Arch Allergy Immunol. 2022 Feb 10:1-9. doi: 10.1159/000521890.
    >> Share

    January 2022
  65. TAKEUCHI H, Takanashi S, Hasan SMT, Hore SK, et al
    Anti-Ascaris IgE as a Risk Factor for Asthma Symptoms among 5-Year-Old Children in Rural Bangladesh with Even Decreased Ascaris Infection Prevalence.
    Int Arch Allergy Immunol. 2022 Jan 31:1-11. doi: 10.1159/000521717.
    >> Share

  66. KAMA Y, Yamada Y, Koike T, Suzuki K, et al
    Antibiotic Treatments Prolong the Wheezing Period in Acute Exacerbation of Childhood Bronchial Asthma.
    Int Arch Allergy Immunol. 2022 Jan 24:1-11. doi: 10.1159/000521192.
    >> Share

  67. FILIOU A, Holmdahl I, Asarnoj A, van Hage M, et al
    Development of Sensitization to Multiple Allergen Molecules from Preschool to School Age Is Related to Asthma.
    Int Arch Allergy Immunol. 2022 Jan 18:1-12. doi: 10.1159/000521324.
    >> Share

  68. FUKUMITSU K, Nishiyama H, Kanemitsu Y, Takeda N, et al
    Pretreatment Alveolar Nitric Oxide Levels Predict Improvement of Pulmonary Function 1 Year Following Anti-Asthma Treatments in Patients with Inhaled Corticosteroid-Naive Asthma.
    Int Arch Allergy Immunol. 2022 Jan 14:1-11. doi: 10.1159/000520508.
    >> Share

  69. SOTO A, Perrone Sibilia M, Sanchez VR, Arcon N, et al
    Contribution of Kazal-Like Domains of the Serine Protease Inhibitor-1 from Toxoplasma gondii in Asthma Therapeutic Vaccination Effectiveness.
    Int Arch Allergy Immunol. 2022 Jan 11:1-8. doi: 10.1159/000520796.
    >> Share

  70. MING X, Yu X, Li J, Wang J, et al
    Salidroside Attenuates Airway Inflammation and Remodeling via the miR-323-3p/SOCS5 Axis in Asthmatic Mice.
    Int Arch Allergy Immunol. 2022;183:424-434.
    >> Share

  71. WANG Z, Zhang J, Yan H, Dong L, et al
    Kawasaki Disease and Atopic Diseases: A Systematic Review and Meta-Analysis of Observational Studies.
    Int Arch Allergy Immunol. 2022;183:389-397.
    >> Share

  72. YOOMA P, Manuyakorn W, Sawatchai A, Jotikasthira W, et al
    Serum Periostin Predicts Wheezing Exacerbation: A Prospective Study in Preschool Children with Recurrent Wheezing.
    Int Arch Allergy Immunol. 2022;183:271-278.
    >> Share

  73. LIU Y, Zhang M, Zhang H, Qian X, et al
    Anthocyanins Inhibit Airway Inflammation by Downregulating the NF-kappaB Pathway via the miR-138-5p/SIRT1 Axis in Asthmatic Mice.
    Int Arch Allergy Immunol. 2022;183:539-551.
    >> Share

  74. LUAN X, Cui C, Jiang J, Wang C, et al
    Salidroside Mitigates Airway Inflammation in Asthmatic Mice via the AMPK/Akt/GSK3beta Signaling Pathway.
    Int Arch Allergy Immunol. 2022;183:326-336.
    >> Share

  75. ZHANG Y, Yan L, Yang J, Li X, et al
    Silencing of FSTL1 Alleviated LPS-Induced Inflammatory Damage and Oxidative Damage in Human Bronchial Epithelial Cells via BMP4/KLF4 Axis.
    Int Arch Allergy Immunol. 2022;183:785-795.
    >> Share

  76. PUXEDDU I, Petrelli F, Cristofani-Mencacci L, Scarano M, et al
    Component-Resolved Diagnosis for Endotyping Patients with Chronic Rhinosinusitis with Nasal Polyps.
    Int Arch Allergy Immunol. 2022;183:770-777.
    >> Share

  77. LOPEZ-RODRIGUEZ R, Rial MJ, Esteban-Gorgojo I, Veleiro Perez B, et al
    Serodominance Profile in a Dust Mite Complex Region.
    Int Arch Allergy Immunol. 2022;183:843-851.
    >> Share

  78. HAN J, Wang W, Zhu Z, Wang L, et al
    Profile of Tissue Immunoglobulin E in Eosinophilic Chronic Rhinosinusitis with Nasal Polyps.
    Int Arch Allergy Immunol. 2022;183:835-842.
    >> Share

  79. LI J, Wang X, Su Y, Hu S, et al
    TRIM33 Modulates Inflammation and Airway Remodeling of PDGF-BB-Induced Airway Smooth-Muscle Cells by the Wnt/beta-Catenin Pathway.
    Int Arch Allergy Immunol. 2022;183:1127-1136.
    >> Share

  80. OZDEL OZTURK B, Yavuz Z, Aydin O, Mungan D, et al
    Effectiveness of Low-Dose Mepolizumab in the Treatment of Eosinophilic Granulomatosis with Polyangiitis (EGPA): A Real-Life Experience.
    Int Arch Allergy Immunol. 2022;183:1281-1290.
    >> Share

    December 2021
  81. GOKMIRZA OZDEMIR P, Celik V
    Current Recommendations on the Management of Pediatric Asthma and Allergic Rhinitis during the COVID-19 Pandemic versus Real-Life Practice.
    Int Arch Allergy Immunol. 2021 Dec 28:1-8. doi: 10.1159/000521117.
    >> Share

  82. HE R, Chen Y, Chen X, Yuan B, et al
    Mechanism of miR-181a-5p in Regulatory T/T-Helper 17 Immune Imbalance and Asthma Development in Mice with Allergic Rhinitis.
    Int Arch Allergy Immunol. 2021 Dec 23:1-14. doi: 10.1159/000519703.
    >> Share

  83. OZDEL OZTURK B, Yavuz Z, Eraslan D, Mungan D, et al
    Mepolizumab Is an Effective Option in Severe Eosinophilic Asthma Regardless of Baseline Features: Single-Center Real-Life Data.
    Int Arch Allergy Immunol. 2021 Dec 14:1-13. doi: 10.1159/000520725.
    >> Share

  84. REINSBERG M, Siebert S, Dreher C, Bogs T, et al
    Predictors of Airway Hyperresponsiveness in Symptomatic Children with Normal Spirometry and Suspicious of Possible Asthma.
    Int Arch Allergy Immunol. 2021 Dec 10:1-9. doi: 10.1159/000520670.
    >> Share

    October 2021
  85. TORRE E, Sola D, Caramaschi A, Mignone F, et al
    A Pilot Study on Clinical Scores, Immune Cell Modulation, and Microbiota Composition in Allergic Patients with Rhinitis and Asthma Treated with a Probiotic Preparation.
    Int Arch Allergy Immunol. 2021 Oct 21:1-15. doi: 10.1159/000518952.
    >> Share

  86. ALABED M, Sultana Shaik A, Saheb Sharif-Askari N, Saheb Sharif-Askari F, et al
    Enhanced Infiltration of Central Memory T Cells to the Lung Tissue during Allergic Lung Inflammation.
    Int Arch Allergy Immunol. 2021 Oct 20:1-15. doi: 10.1159/000518835.
    >> Share

  87. KOYA T, Sakai N, Sasaki T, Shinbori K, et al
    Effect of Dupilumab on Depression in Asthma with Eosinophilic Chronic Rhinosinusitis in the Japanese Population.
    Int Arch Allergy Immunol. 2021 Oct 15:1-9. doi: 10.1159/000519296.
    >> Share

  88. PAN HH, Ko JL, Wu CT, Sun HL, et al
    Effect of the Fungal Immunomodulatory Protein FIP-fve in the Neutrophilic Asthma Animal Model.
    Int Arch Allergy Immunol. 2021 Oct 14:1-12. doi: 10.1159/000517184.
    >> Share

    September 2021
  89. INOUE H, Akimoto K, Ikeda H, Sato H, et al
    Comprehensive Gene Expression Signature Using RNA-Seq in Airways of Mouse Model of Severe Asthma with Fungal Sensitization.
    Int Arch Allergy Immunol. 2021 Sep 29:1-11. doi: 10.1159/000519172.
    >> Share

  90. VENTURA MT, Giuliano AFM, Buquicchio R, Bedbrook A, et al
    Implementation of the MASK-Air(R) App for Rhinitis and Asthma in Older Adults: MASK@Puglia Pilot Study.
    Int Arch Allergy Immunol. 2021 Sep 22:1-6. doi: 10.1159/000518032.
    >> Share

  91. SAHINER UM, Arik Yilmaz E, Fontanella S, Haider S, et al
    The Montelukast Therapy in Asthmatic Children with and without Food Allergy: Does It Make Any Difference?
    Int Arch Allergy Immunol. 2021 Sep 9:1-10. doi: 10.1159/000517865.
    >> Share

    January 2021
  92. METBULUT AP, Mustafaoglu O, Sen G, Kanik Yuksek S, et al
    Evaluation of the Clinical and Laboratory Findings of Asthmatic Children with SARS-CoV-2 Infection.
    Int Arch Allergy Immunol. 2021;182:989-996.
    >> Share

  93. HE Y, Liu J, Zhao D, Zhang S, et al
    The IgE Blocking Activity Induced by Dermatophagoides pteronyssinus Subcutaneous Immunotherapy Does Not Correlate with Specific IgA but with IgG4 in both Serum and Saliva.
    Int Arch Allergy Immunol. 2021;182:1231-1244.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016